603231 索宝蛋白
已收盘 02-13 15:00:00
资讯
新帖
简况
索宝蛋白跌5.22% 2023年上市超募4.2亿元
中金财经 · 02-12 17:24
索宝蛋白跌5.22% 2023年上市超募4.2亿元
每周股票复盘：索宝蛋白（603231）每股派现0.07元（含税）
证券之星 · 02-08
每周股票复盘：索宝蛋白（603231）每股派现0.07元（含税）
索宝蛋白(603231.SH)2025年前三季度权益分派：每股派利0.07元
中金财经 · 02-05
索宝蛋白(603231.SH)2025年前三季度权益分派：每股派利0.07元
每周股票复盘：索宝蛋白（603231）完成工商变更并推股东回报规划
证券之星 · 01-18
每周股票复盘：索宝蛋白（603231）完成工商变更并推股东回报规划
索宝蛋白（603231）披露2025年中期利润分配方案及未来三年股东回报规划，1月16日股价下跌0.97%
证券之星 · 01-16
索宝蛋白（603231）披露2025年中期利润分配方案及未来三年股东回报规划，1月16日股价下跌0.97%
每周股票复盘：索宝蛋白（603231）2025中期拟每股派0.7元
证券之星 · 01-11
每周股票复盘：索宝蛋白（603231）2025中期拟每股派0.7元
索宝蛋白（603231）披露2025年中期利润分配方案，1月9日股价上涨0.38%
证券之星 · 01-09
索宝蛋白（603231）披露2025年中期利润分配方案，1月9日股价上涨0.38%
索宝蛋白（603231）披露2025年度持续督导现场检查报告，1月7日股价下跌0.11%
证券之星 · 01-07
索宝蛋白（603231）披露2025年度持续督导现场检查报告，1月7日股价下跌0.11%
索宝蛋白（603231）披露召开2026年第一次临时股东会通知，1月5日股价上涨0.82%
证券之星 · 01-05
索宝蛋白（603231）披露召开2026年第一次临时股东会通知，1月5日股价上涨0.82%
每周股票复盘：索宝蛋白（603231）拟每10股派0.70元
证券之星 · 01-02
每周股票复盘：索宝蛋白（603231）拟每10股派0.70元
每周股票复盘：索宝蛋白（603231）变更募投项目实施主体
证券之星 · 2025-12-28
每周股票复盘：索宝蛋白（603231）变更募投项目实施主体
索宝蛋白（603231）披露开立募集资金专项账户并签订四方监管协议公告，12月23日股价下跌0.32%
证券之星 · 2025-12-23
索宝蛋白（603231）披露开立募集资金专项账户并签订四方监管协议公告，12月23日股价下跌0.32%
12月8日索宝蛋白发布公告，股东减持29.8万股
证券之星 · 2025-12-08
12月8日索宝蛋白发布公告，股东减持29.8万股
索宝蛋白股东计划减持股份
投资观察 · 2025-11-20
索宝蛋白股东计划减持股份
索宝蛋白（603231）披露取消监事会及修改公司章程议案获通过，11月17日股价下跌0.71%
证券之星 · 2025-11-17
索宝蛋白（603231）披露取消监事会及修改公司章程议案获通过，11月17日股价下跌0.71%
每周股票复盘：索宝蛋白（603231）拟取消监事会并变更募投项目
证券之星 · 2025-11-16
每周股票复盘：索宝蛋白（603231）拟取消监事会并变更募投项目
索宝蛋白（603231）披露股东减持股份计划公告，11月12日股价下跌1.77%
证券之星 · 2025-11-12
索宝蛋白（603231）披露股东减持股份计划公告，11月12日股价下跌1.77%
索宝蛋白(603231.SH)：济南复星、宁波复星拟合计减持不超3%股份
智通财经 · 2025-11-11
索宝蛋白(603231.SH)：济南复星、宁波复星拟合计减持不超3%股份
索宝蛋白（603231）披露拟取消监事会并变更部分募投项目，11月10日股价上涨1.88%
证券之星 · 2025-11-10
索宝蛋白（603231）披露拟取消监事会并变更部分募投项目，11月10日股价上涨1.88%
索宝蛋白：截至2025年10月31日，公司股东人数为17895户
证券日报 · 2025-11-04
索宝蛋白：截至2025年10月31日，公司股东人数为17895户
加载更多
公司概况
公司名称：
宁波索宝蛋白科技股份有限公司
所属行业：
农副食品加工业
上市日期：
2023-12-15
主营业务：
宁波索宝蛋白科技股份有限公司的主营业务是大豆蛋白系列产品的研发、生产和销售。公司的主要产品是大豆分离蛋白、大豆浓缩蛋白、组织化蛋白、大豆膳食纤维及非转基因大豆油。
发行价格：
21.29
{"stockData":{"symbol":"603231","market":"SH","secType":"STK","nameCN":"索宝蛋白","latestPrice":18.71,"timestamp":1770966001000,"preClose":18.7,"halted":0,"volume":3320460,"delay":0,"changeRate":0.0005,"floatShares":106000000,"shares":191000000,"eps":0.9203,"marketStatus":"已收盘","change":0.01,"latestTime":"02-13 15:00:00","open":18.78,"high":18.88,"low":18.66,"amount":62421400,"amplitude":0.0118,"askPrice":18.71,"askSize":335,"bidPrice":18.7,"bidSize":60,"shortable":0,"etf":0,"ttmEps":0.9203,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":18.7,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":20.57,"lowLimit":16.83,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":191459105,"isCdr":false,"pbRate":1.82,"roa":"--","peRate":20.330327,"roe":"7.66%","epsLYR":0.63,"committee":0.002208,"marketValue":3582000000,"turnoverRate":0.0312,"status":0,"floatMarketCap":1988000000},"requestUrl":"/m/hq/s/603231","defaultTab":"news","newsList":[{"id":"2610946125","title":"索宝蛋白跌5.22% 2023年上市超募4.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946125","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610946125?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:24","pubTimestamp":1770888259,"startTime":"0","endTime":"0","summary":"中国经济网北京2月12日讯 索宝蛋白 今日收报18.70元，跌幅5.22%。 索宝蛋白首次公开发行募集资金总额101,904.16万元，募集资金净额97,945.57万元。索宝蛋白最终募集资金净额比原计划多42,487.31万元。 索宝蛋白公开发行新股的发行费用合计3,958.59万元(不含税)，其中承销及保荐费用2,735.85万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260212/32015294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2609254975","title":"每周股票复盘：索宝蛋白（603231）每股派现0.07元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2609254975","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609254975?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:10","pubTimestamp":1770487826,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，索宝蛋白报收于19.96元，较上周的19.92元上涨0.2%。本周，索宝蛋白2月5日盘中最高价报20.3元。本周关注点公司公告汇总：索宝蛋白每股派发现金红利0.07元（含税），股权登记日为2026年2月11日。公司公告汇总宁波索宝蛋白科技股份有限公司2025年前三季度权益分派实施公告：每股派发现金红利0.07元（含税），股权登记日为2026年2月11日，除权（息）日为2026年2月12日，现金红利发放日为2026年2月12日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2609237733","title":"索宝蛋白(603231.SH)2025年前三季度权益分派：每股派利0.07元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609237733","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609237733?lang=zh_cn&edition=full","pubTime":"2026-02-05 20:17","pubTimestamp":1770293821,"startTime":"0","endTime":"0","summary":"格隆汇2月5日丨索宝蛋白(603231.SH)公布2025年前三季度权益分派实施公告,本次利润分配以方案实施前的公司总股本191,459,105股为基数，每股派发现金红利0.07元(含税)，共计派发现金红利13,402,137.35元。\r\n\r\n 本次权益分派股权登记日为：2026年2月11日，除权除息日为：2026年2月12日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260205/32001598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2604329925","title":"每周股票复盘：索宝蛋白（603231）完成工商变更并推股东回报规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2604329925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604329925?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:42","pubTimestamp":1768678929,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，索宝蛋白报收于19.45元，较上周的18.73元上涨3.84%。公司公告汇总关于完成工商变更登记的公告宁波索宝蛋白科技股份有限公司于2026年1月13日发布公告，称公司已完成工商变更登记及公司章程备案工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2603197994","title":"索宝蛋白（603231）披露2025年中期利润分配方案及未来三年股东回报规划，1月16日股价下跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603197994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603197994?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:41","pubTimestamp":1768574469,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，索宝蛋白报收于19.45元，较前一交易日下跌0.97%，最新总市值为37.24亿元。该股当日开盘19.57元，最高19.74元，最低19.34元，成交额达7463.1万元，换手率为3.6%。近日，宁波索宝蛋白科技股份有限公司召开2026年第一次临时股东会，审议通过了关于2025年中期利润分配方案的议案和关于未来三年股东回报规划的议案。两项议案均获得出席股东所持表决权过半数通过，中小股东的表决情况已单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600041387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2602536455","title":"每周股票复盘：索宝蛋白（603231）2025中期拟每股派0.7元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602536455","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602536455?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:04","pubTimestamp":1768075451,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，索宝蛋白报收于18.73元，较上周的18.32元上涨2.24%。本周，索宝蛋白1月8日盘中最高价报18.75元。2025年中期利润分配方案拟以2025年末总股本191,459,105股为基数，向全体股东每10股派发现金股利0.70元（含税），合计分配利润13,402,137.35元（含税），该分红金额占2025年前三季度归属于母公司股东净利润的9.14%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2602372303","title":"索宝蛋白（603231）披露2025年中期利润分配方案，1月9日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602372303","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602372303?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:47","pubTimestamp":1767970030,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，索宝蛋白报收于18.73元，较前一交易日上涨0.38%，最新总市值为35.86亿元。根据公告内容，该利润分配方案拟以2025年末总股本191,459,105股为基数，向全体股东每10股派发现金股利0.70元（含税），合计分配利润13,402,137.35元（含税）。现金分红占2025年前三季度归母净利润的9.14%。如股权登记日前公司总股本发生变动，将维持每股分配比例不变，相应调整分配总额。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2601801125","title":"索宝蛋白（603231）披露2025年度持续督导现场检查报告，1月7日股价下跌0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801125","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801125?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:34","pubTimestamp":1767796458,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，索宝蛋白报收于18.53元，较前一交易日下跌0.11%，最新总市值为35.48亿元。近日，东吴证券股份有限公司发布了关于宁波索宝蛋白科技股份有限公司2025年度持续督导工作现场检查报告。公告显示，东吴证券作为索宝蛋白首次公开发行股票并在主板上市的保荐人，于2025年12月29日至12月31日对索宝蛋白开展了2025年度持续督导现场检查。检查过程中未发现需向监管部门报告的重大事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700039109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2601913000","title":"索宝蛋白（603231）披露召开2026年第一次临时股东会通知，1月5日股价上涨0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601913000","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601913000?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:21","pubTimestamp":1767608473,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，索宝蛋白报收于18.47元，较前一交易日上涨0.82%，最新总市值为35.36亿元。该股当日开盘18.32元，最高18.5元，最低18.28元，成交额达4586.45万元，换手率为2.34%。近日，宁波索宝蛋白科技股份有限公司发布公告，宣布将于2026年1月16日召开2026年第一次临时股东会，会议采取现场投票与网络投票相结合方式。股权登记日为2026年1月9日。本次股东会将审议2025年中期利润分配方案及未来三年股东回报规划。中小投资者对上述两项议案将单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500028595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2600610039","title":"每周股票复盘：索宝蛋白（603231）拟每10股派0.70元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600610039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600610039?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:59","pubTimestamp":1767297547,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，索宝蛋白报收于18.5元，较上周的18.63元下跌0.7%。本周，索宝蛋白12月22日盘中最高价报18.75元。本周关注点公司公告汇总：索宝蛋白拟每10股派发现金红利0.70元（含税）。截至2025年12月31日，公司总股本为191,459,105股，拟分配利润13,402,137.35元（含税），占2025年前三季度归母净利润的9.14%。若股权登记日前总股本变动，将维持每股分配比例不变，相应调整总额。会议表决结果为同意6票，反对0票，弃权0票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2594024799","title":"每周股票复盘：索宝蛋白（603231）变更募投项目实施主体","url":"https://stock-news.laohu8.com/highlight/detail?id=2594024799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594024799?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:09","pubTimestamp":1766869751,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，索宝蛋白报收于18.5元，较上周的18.63元下跌0.7%。本周，索宝蛋白12月22日盘中最高价报18.75元。本周关注点公司公告汇总：索宝蛋白将原大豆颗粒蛋白项目变更为高端大豆分离蛋白生产线改造项目，实施主体变更为山东万得福生物科技有限公司。公司公告汇总宁波索宝蛋白科技股份有限公司于2023年12月完成首次公开发行，募集资金净额97,945.57万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2593876499","title":"索宝蛋白（603231）披露开立募集资金专项账户并签订四方监管协议公告，12月23日股价下跌0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593876499","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593876499?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:58","pubTimestamp":1766483936,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，索宝蛋白报收于18.56元，较前一交易日下跌0.32%，最新总市值为35.53亿元。该股当日开盘18.61元，最高18.71元，最低18.51元，成交额达2700.78万元，换手率为1.37%。近日，宁波索宝蛋白科技股份有限公司发布关于开立募集资金专项账户并签订募集资金存储四方监管协议的公告。公告显示，公司于2023年12月完成首次公开发行，募集资金净额97,945.57万元。专户资金使用受严格监管，超5000万元或达募集资金净额20%的支出需及时通知保荐人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300029438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2589334778","title":"12月8日索宝蛋白发布公告，股东减持29.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2589334778","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589334778?lang=zh_cn&edition=full","pubTime":"2025-12-08 19:01","pubTimestamp":1765191695,"startTime":"0","endTime":"0","summary":"证券之星消息，12月8日索宝蛋白发布公告《索宝蛋白:关于持股5%以上股东权益变动触及1%刻度的提示性公告》，其股东上海复星创富投资管理股份有限公司-宁波梅山保税港区复星惟盈股权投资基金合伙企业、济南财金复星惟实股权投资基金合伙企业于2025年12月4日至2025年12月5日间合计减持29.8万股，占公司目前总股本的0.1556%，变动期间该股股价下跌1.57%，截止12月5日收盘报19.42元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800025187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"1154783475","title":"索宝蛋白股东计划减持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1154783475","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154783475?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:22","pubTimestamp":1763572943,"startTime":"0","endTime":"0","summary":"11月11日，索宝蛋白技术有限公司（603231.SS）宣布，股东们计划减持公司总计约3%的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2584621793","title":"索宝蛋白（603231）披露取消监事会及修改公司章程议案获通过，11月17日股价下跌0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584621793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584621793?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:26","pubTimestamp":1763389587,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘，索宝蛋白报收于21.08元，较前一交易日下跌0.71%，最新总市值为40.36亿元。该股当日开盘21.2元，最高21.4元，最低20.88元，成交额达6248.1万元，换手率为2.8%。近日，宁波索宝蛋白科技股份有限公司召开2025年第一次临时股东大会，会议审议通过了关于取消监事会、修改《公司章程》的议案，以及修订公司多项管理制度的议案，包括《股东会议事规则》《董事会议事规则》《募集资金管理制度》等。所有议案均获有效通过，表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700037118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2583965166","title":"每周股票复盘：索宝蛋白（603231）拟取消监事会并变更募投项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2583965166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583965166?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:30","pubTimestamp":1763235037,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，索宝蛋白报收于21.23元，较上周的20.19元上涨5.15%。本周关注点公司公告汇总：索宝蛋白拟取消监事会，职权由董事会审计委员会行使。股东减持股份计划公告宁波索宝蛋白科技股份有限公司股东济南复星和宁波复星合计持有公司股份14.074%，因自身资金需求，拟通过集中竞价或大宗交易方式减持合计不超过5,743,772股，即不超过公司总股本的3%。本次减持不会导致公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2582732170","title":"索宝蛋白（603231）披露股东减持股份计划公告，11月12日股价下跌1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582732170","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582732170?lang=zh_cn&edition=full","pubTime":"2025-11-12 17:35","pubTimestamp":1762940131,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，索宝蛋白报收于21.66元，较前一交易日下跌1.77%，最新总市值为41.47亿元。该股当日开盘21.25元，最高21.78元，最低21.22元，成交额达1.42亿元，换手率为6.24%。公司近日发布公告称，宁波索宝蛋白科技股份有限公司股东济南复星和宁波复星合计持有公司股份14.074%，因自身资金需求，拟通过集中竞价或大宗交易方式减持合计不超过5,743,772股，即不超过公司总股本的3%。本次减持不会导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200028752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2582436532","title":"索宝蛋白(603231.SH)：济南复星、宁波复星拟合计减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2582436532","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582436532?lang=zh_cn&edition=full","pubTime":"2025-11-11 19:53","pubTimestamp":1762861980,"startTime":"0","endTime":"0","summary":"智通财经APP讯，索宝蛋白(603231.SH)发布公告，济南复星、宁波复星拟通过集中竞价或大宗交易方式减持公司股份合计不超过574.38万股，即不超过公司总股本的3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0238","603231"],"gpt_icon":0},{"id":"2582870576","title":"索宝蛋白（603231）披露拟取消监事会并变更部分募投项目，11月10日股价上涨1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582870576","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582870576?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:44","pubTimestamp":1762785861,"startTime":"0","endTime":"0","summary":"截至2025年11月10日收盘，索宝蛋白报收于20.57元，较前一交易日上涨1.88%，最新总市值为39.38亿元。该股当日开盘20.19元，最高20.75元，最低20.04元，成交额达8089.23万元，换手率为3.73%。公司近日发布公告称，宁波索宝蛋白科技股份有限公司拟取消监事会，监事会职权由董事会审计委员会行使，并修改《公司章程》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000035006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"gpt_icon":0},{"id":"2580730542","title":"索宝蛋白：截至2025年10月31日，公司股东人数为17895户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580730542","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580730542?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:36","pubTimestamp":1762263360,"startTime":"0","endTime":"0","summary":"证券日报网讯索宝蛋白11月4日在互动平台回答投资者提问时表示，截至2025年10月31日，公司股东人数为17，895户。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-04/doc-infwhekh9765296.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-04/doc-infwhekh9765296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603231","BK0238"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771085336850,"stockEarnings":[{"period":"1week","weight":-0.0593},{"period":"1month","weight":-0.0159},{"period":"3month","weight":-0.1156},{"period":"6month","weight":0.0916},{"period":"1year","weight":0.1885},{"period":"ytd","weight":0.0249}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波索宝蛋白科技股份有限公司","boardCode":"AI0013","boardName":"农副食品加工业","stockholders":"16229人(较上一季度增加2.13%)","perCapita":"6547股","listingDate":"2023-12-15","address":"浙江省宁波市北仑区保税区兴业大道12号","registeredCapital":"19145万元","survey":" 宁波索宝蛋白科技股份有限公司的主营业务是大豆蛋白系列产品的研发、生产和销售。公司的主要产品是大豆分离蛋白、大豆浓缩蛋白、组织化蛋白、大豆膳食纤维及非转基因大豆油。","listedPrice":21.29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"索宝蛋白(603231)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供索宝蛋白(603231)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"索宝蛋白,603231,索宝蛋白股票,索宝蛋白股票老虎,索宝蛋白股票老虎国际,索宝蛋白行情,索宝蛋白股票行情,索宝蛋白股价,索宝蛋白股市,索宝蛋白股票价格,索宝蛋白股票交易,索宝蛋白股票购买,索宝蛋白股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"索宝蛋白(603231)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供索宝蛋白(603231)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}